Team:Paris/August 18

From 2008.igem.org

(Difference between revisions)
(→Miniprep and stock glycerol)
Line 20: Line 20:
-
='''Miniprep and stock glycerol'''=
+
=='''Miniprep and stock glycerol of L151'''==
-
 
+
-
==Stock Glycerol of New Biobrick==
+
*[[Team:Paris/Notebook/Protocols#Glycerol stocks| Protocol stocks]]
*[[Team:Paris/Notebook/Protocols#Glycerol stocks| Protocol stocks]]
{|border="1" style="text-align: center"
{|border="1" style="text-align: center"
|'''Stock number'''
|'''Stock number'''
 +
|'''Ligation name'''
|'''Biobricks'''
|'''Biobricks'''
|'''Description'''
|'''Description'''
|-
|-
-
|S163.1
+
|S162.1
-
|rowspan="2"| B0032
+
|L151.1
-
|rowspan="2"| RBS
+
|rowspan="3" |[[Image:Part_icon_rbs.png]][[Image:icon_coding.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]]
 +
|rowspan="3" |rbs-LasR - Double terminator
|-
|-
-
|S163.2
+
|S162.2
 +
|L151.2
|-
|-
-
|S164.1
+
|S162.3
-
|rowspan="2"| E0422
+
|L151.3
-
|rowspan="2"| RBS+ ECFP+ LVA+ term
+
-
|-
+
-
|S164.2
+
-
|-
+
-
|S165.1
+
-
|rowspan="2"| E0430
+
-
|rowspan="2"| RBS+ YFP+ LVA- term
+
-
|-
+
-
|S165.2
+
-
|-
+
-
|S166.1
+
-
|rowspan="2"| E0432
+
-
|rowspan="2"| RBS+ YFP LVA+ term
+
-
|-
+
-
|S166.2
+
-
|-
+
-
|S167.1
+
-
|rowspan="2"| E0420
+
-
|rowspan="2"| RBS+ ECFP LVA- term
+
-
|-
+
-
|S167.2
+
-
|-
+
-
|S168.1
+
-
|rowspan="2"| I732078
+
-
|rowspan="2"| RBS+ mRFP LVA+ term
+
-
|-
+
-
|S168.2
+
|}
|}
-
==Miniprep of New Biobricks==
+
 
-
*[[Team:Paris/Notebook/Protocols#Minipreps (Kit_Qiagen)| Protocol Miniprep]]
+
*[[Team:Paris/Notebook/Protocols#Minipreps (Kit_Qiagen)| Protocol minprep]]
 +
 
{|border="1" style="text-align: center"
{|border="1" style="text-align: center"
-
|'''Miniprep'''
+
|'''Miniprep Name'''
 +
|'''Ligation name'''
 +
|'''Antibio'''
|'''Biobricks'''
|'''Biobricks'''
|'''Description'''
|'''Description'''
|-
|-
-
|MP163.1
+
|MP162.1
-
|rowspan="2"| B0032
+
|L151.1
-
|rowspan="2"| RBS
+
|rowspan="3" |Kan
-
|-
+
|rowspan="3" |[[Image:Part_icon_rbs.png]][[Image:icon_coding.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]]
-
|MP163.2
+
|rowspan="3" |rbs-LasR - Double terminator
-
|-
+
-
|MP164.1
+
-
|rowspan="2"| E0422
+
-
|rowspan="2"| RBS+ ECFP+ LVA+ term
+
-
|-
+
-
|MP164.2
+
-
|-
+
-
|MP165.1
+
-
|rowspan="2"| E0430
+
-
|rowspan="2"| RBS+ YFP+ LVA- term
+
-
|-
+
-
|MP165.2
+
-
|-
+
-
|MP166.1
+
-
|rowspan="2"| E0432
+
-
|rowspan="2"| RBS+ YFP LVA+ term
+
-
|-
+
-
|MP166.2
+
-
|-
+
-
|MP167.1
+
-
|rowspan="2"| E0420
+
-
|rowspan="2"| RBS+ ECFP LVA- term
+
-
|-
+
-
|MP167.2
+
|-
|-
-
|MP168.1
+
|MP162.2
-
|rowspan="2"| I732078
+
|L151.2
-
|rowspan="2"| RBS+ mRFP LVA+ term
+
|-
|-
-
|MP168.2
+
|MP162.3
 +
|L151.3
|}
|}

Revision as of 17:40, 20 August 2008

← Yesterday

↓ Calendar ↑

Tomorrow →

Contents

Analysis of the cloning of OmpR* and EnvZ*

PCR screening

  • positive control: S158 (pSB3K3)
  • negative control: no template
  • screening PCR programm
  • elongation time: 1 min 30
  • primers: O18 & O19

Reaction mixture (25 µL total volume)

  • 12,5 µL Quick load PCR Mix
  • 0,5 µL O18
  • 0,5 µL O19
  • 12 µL water

We wanted to analyse the transformants of the ligations L133 (OmpR* in pSB1A2) and L134 (EnvZ* in pSB1A2) from the experience of august 9th/11th.
3 clones of L133 and 3 clones of L134 were analysed.
Each clone tested was then cultured in 7,5 mL LB + ampicilline.


Miniprep and stock glycerol of L151

Stock number Ligation name Biobricks Description
S162.1 L151.1 Part icon rbs.pngIcon coding.pngPart icon terminator.pngPart icon terminator.png rbs-LasR - Double terminator
S162.2 L151.2
S162.3 L151.3


Miniprep Name Ligation name Antibio Biobricks Description
MP162.1 L151.1 Kan Part icon rbs.pngIcon coding.pngPart icon terminator.pngPart icon terminator.png rbs-LasR - Double terminator
MP162.2 L151.2
MP162.3 L151.3

Digestion of MP162

Measurement of the concentration of MPs 162

Miniprep Name Concentration (µg/mL) Ratio 260/280
MP162.1 151 1.71
MP162.2 172 1.73
MP162.3 149 1.73

Digestion

Protocol

Digestion name Template DNA Enzymes Volume of DNA
D165 MP162.2 XbaI - PstI 5.81 µL

Gel Extraction

Gel Extraction of D165

Protocol


Well Sample Expected size Measured size
1 1kb ladder
2 MP162.2 2855 3000
3 no sample
4 D165.2 2057 / 798 2000 / 800
5 no sample
6 100pb ladder

Ligation

Protocol

Ligation Name Vector Name Volume Vector (µL) Insert Volume Insert (µL)
L153 D123.1 1.54 D165 1.69
L154 D103.2 1.14 D165 1.68
Control L153 D123.1 1.54 - -
Control L154 D103.2 1.14 - -

Culture of stable strains with biobrocks 2008

Protocol

Biobrick Name Part Description
B0032 in pSB1A2 rbs (efficiency=0.3) Icon rbs.png
E0422 in pSB1A2 ECFP (LVA+) Icon rbs.pngIcon reporter.pngPart icon terminator.pngPart icon terminator.png
E0420 in pSB1A2 ECFP (LVA-) Icon rbs.pngIcon reporter.pngPart icon terminator.pngPart icon terminator.png
E0430 in pSB1A2 EYFP (LVA-) Icon rbs.pngIcon reporter.pngPart icon terminator.pngPart icon terminator.png
E0432 in pSB1A2 EYFP (LVA+) Icon rbs.pngIcon reporter.pngPart icon terminator.pngPart icon terminator.png
I732078 in pSB1A3 mRFP1 (LVA+) Icon rbs.pngIcon reporter.pngPart icon terminator.pngPart icon terminator.png
I13507 in pSB1A2 mRFP1 (LVA-) Icon rbs.pngIcon reporter.pngPart icon terminator.pngPart icon terminator.png
Retrieved from "http://2008.igem.org/Team:Paris/August_18"